Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System
NCT ID: NCT00734981
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2012-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Semen Analysis Tests As a Screening Tool for Fertility Patients
NCT06188936
Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine
NCT04778033
Seminal Levels of PGK2 and ACRV1 as Predictors of Micro-TESE Results in NOA
NCT06307639
Male Factor Infertility Across India Using Aphrodite Criteria
NCT06911840
Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment
NCT00731159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Semen volume, semen pH, leukocytes concentration, sperm cells concentration, motile sperm cell concentration, total motile sperm cells threshold and sperm cells morphology
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20\<Age\<45
* Male
Exclusion Criteria
20 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lotus Bio Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assuta Medical Centers Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuta Medical Centers Ltd.
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LBI-02-V2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.